Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Knowledge Translation for Patients With Acute Coronary Syndromes
- Status
- COMPLETED
- Phase
- NA
Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control
- Status
- COMPLETED
- Phase
- NA
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
- Status
- COMPLETED
- Phase
- PHASE4
REAnimation Low Immune Status Markers
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE1
Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
- Status
- COMPLETED
- Phase
- PHASE4
Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo
- Status
- COMPLETED
- Phase
- PHASE3